Herpes zoster ophthalmicus

Journal of the Royal Society of Medicine

Volumn 90, Issue 12, 1997, Pages 670-674

  Marsh, Ronald J ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMANTADINE; ANTIINFLAMMATORY AGENT; ANTIVIRUS AGENT; CHICKENPOX VACCINE; CHLOROQUINE; HEPARIN; RIFAMPICIN; STEROID; VIRUS DNA;

AGING; CELLULAR IMMUNITY; CHICKENPOX; CLINICAL FEATURE; DISEASE COURSE; HERPES ZOSTER OPHTHALMICUS; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; OPHTHALMIC NERVE; PATHOGENESIS; RASH; RECURRENT DISEASE; SEROPREVALENCE; SHORT SURVEY; SPINAL GANGLION; SYMPTOMATOLOGY; TRIGEMINUS GANGLION; VACCINATION; VIRUS ACTIVATION; VIRUS SHEDDING;

EID: 0031448903     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1177/014107689709001209     Document Type: Short Survey

References (25)

1. von Barensprung FGF. Die Gurtelkrankeit. Ann Char krankenh 1861;9:40
2. Hutchinson J. Clinical report on herpes zoster frontalis ophthalmicus. Ophth Hosp Rep 1864;3:72, 865 6;5:191, 1867 9;6:181
3. Hutchinson J. Clinical report on herpes zoster frontalis ophthalmicus. Ophth Hosp Rep 1864;3:72, 865 6;5:191, 1867 9;6:181
4. Hutchinson J. Clinical report on herpes zoster frontalis ophthalmicus. Ophth Hosp Rep 1864;3:72, 865 6;5:191, 1867 9;6:181
5. Bowman W. Case of zoster, or unilateral confluent herpes of ophthalmic region. Ophth Hosp Rep 1867 9;6:1
6. Weller TH. Serial propagation (in vitro) of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med 1953;85:340-6
7. Hyman RW, Ecker JR, Tenser RB. Varicella-zoster virus RNA in human trigeminal ganglia. Lancet 1983:ii:814-16
8. Weller TH. Varicella and herpes zoster. N Engl J Med 1982;309:1362 68, 1434-39
9. Marsh RJ. Herpes zoster ophthalmicus. Br J Hosp Med 1976;15:609-18
10. Marsh RJ, Cooper M. Ophthalmic herpes zoster. Eye 1993;7:350-70
11. Weksler MF. Immune senescence. Ann Neurol 1992;35:S35-S37
12. Straus SE. Overview; the biology of varicella zoster virus infection. Ann Neurol 1992;35:S4-S8
13. Naumann G, Gass JDM, Font RL. Histopathology of herpes zoster ophthalmius. Am J Ophthalmol 1968;65:533
14. Hope-Simpson RE. The nature of herpes zoster; a long term study and a new hypothesis. Proc R Soc Med 1965;58:9-20
15. Cradock-Watson JE, Ridehalgh MKS, Bourne MS. Specific immunoglobulin responses after varicella and herpes zoster. J Hyg 1979;82:319-36
16. Nielsen H, Olholm P, Feldt Rasmussen U, Godtfredsen A, Svehag SE, Circulating immune complexes and complement-fixing antibodies in patients with varicella zoster infection: relationship to debut of the disease. Scand J Infect Dis 1980;12:21-6
17. Weller TH. Varicella and herpes zoster. N Engl J Med 1982;309:1362 68, 1434-39
18. Stevens DA, Merrigan TC. Interferon, antibody and other host factors in herpes zoster J Clin Invest 1972;51:1170
19. Kestelyn P, Stevens AM, Bakkers E, Rouvray D, Van de Perre P. Severe herpes zoster ophthalmicus in young African adults: a marker for HTI.V-III seropositivity. Br J Ophthalmol 1987;71:806-9
20. Marsh RJ. Herpes zoster ophthalmicus and AIDS. Br J Ophthalmol 1987;71:805
21. McKendrick MW, McGill JL, Bell AM, Hickmott E, Murke C. Oral acyclovir for herpes zoster. Lancet 1984;ii:925
22. Cobo IM, Foulks GN, Leisgang T, Lass J, Sutprin JE, Wilhelmus K. Oral acyclovir in the therapy of acute herpes zoster ophthalmicus. An interim report. Ophthalmology 1985;92:1574-83
23. McKendrick MW, McGill JJI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989;298:431
24. Aylward GW, Claoue CM, Marsh RJ. Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus. Eye 1994;8:70-4
25. Marsh RJ, Cooper M. Double-masked trial of topical acyclovir and steroids in the treatment of herpes zoster ocular inflammation. Br J Ophthalmol 1991;75:542-46